全文获取类型
收费全文 | 1498篇 |
免费 | 164篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 16篇 |
妇产科学 | 7篇 |
基础医学 | 80篇 |
临床医学 | 46篇 |
内科学 | 14篇 |
皮肤病学 | 1094篇 |
神经病学 | 14篇 |
特种医学 | 4篇 |
外科学 | 98篇 |
综合类 | 101篇 |
预防医学 | 9篇 |
眼科学 | 7篇 |
药学 | 81篇 |
中国医学 | 70篇 |
肿瘤学 | 32篇 |
出版年
2024年 | 20篇 |
2023年 | 92篇 |
2022年 | 60篇 |
2021年 | 79篇 |
2020年 | 152篇 |
2019年 | 118篇 |
2018年 | 86篇 |
2017年 | 55篇 |
2016年 | 62篇 |
2015年 | 50篇 |
2014年 | 108篇 |
2013年 | 104篇 |
2012年 | 52篇 |
2011年 | 78篇 |
2010年 | 63篇 |
2009年 | 50篇 |
2008年 | 52篇 |
2007年 | 39篇 |
2006年 | 49篇 |
2005年 | 37篇 |
2004年 | 33篇 |
2003年 | 33篇 |
2002年 | 30篇 |
2001年 | 27篇 |
2000年 | 13篇 |
1999年 | 18篇 |
1998年 | 19篇 |
1997年 | 8篇 |
1996年 | 10篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 5篇 |
1991年 | 5篇 |
1990年 | 8篇 |
1989年 | 6篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 3篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1982年 | 5篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有1675条查询结果,搜索用时 31 毫秒
991.
富血小板血浆(PRP)富含生长因子、细胞因子等多种生物活性物质,具有促进细胞增殖、分化、基质合成、组织再生与修复等作用。其制作过程虽不复杂,但全球仍没有一个统一的制作标准。 近年来已有多个实验及临床研究证明PRP治疗雄激素型脱发(AGA)有效且安全。治疗方法除了单纯头皮下注射PRP,还衍生出PRP联合微针、药物、脂肪移植、低能量激光疗法、非剥脱性Er:YAG等。本文整理分析近年来相关文献及实验,综述PRP在治疗AGA的作用机制、制备方法、治疗方法等方面的研究进展,为临床医生提供更多理论及实践依据。 相似文献
992.
Giovanni Brotzu Anna Maria Fadda Maria Letizia Manca Thomas Manca Francesca Marongiu Monica Campisi Francesca Consolaro 《Dermatologic therapy》2019,32(1)
Hair loss is a common aesthetic disorder that can be triggered by genetic, inflammatory, hormonal, and environmental factors acting on hair follicles and their life cycle. There are several types of hair loss that differ in causes, symptoms, and spatial and temporal progression. Androgenic alopecia, a common form of hair loss, is the consequence of a decreased microcirculation of the scalp as well as the toxic action of elevated dihydrotestosterone levels on the hair bulbs. In the present study, the lotions TRINOV Lozione Anticaduta Uomo and TRINOV Lozione Anticaduta Donna, containing dihomo‐γ‐linolenic acid (DGLA), S‐equol, and propionyl‐l ‐carnitine, were tested on 30 men and 30 women (mean age of men was 46.6 ± 6.4 years; mean age of women was 49.5 ± 9.0) with signs of androgenic alopecia, respectively. DGLA is a precursor of the prostaglandin PGE1, which acts by improving microcirculation; S‐equol inhibits 5α‐reductases, thus preventing the transformation of testosterone into dihydrotestosterone; and propionyl‐l ‐carnitine promotes lipid metabolism, stimulating energy production. These three molecules are loaded into liposomes for their effective transdermal delivery. Daily topical applications of the lotions resulted in a hair count that significantly increased for women and marginally increased for men after 6 months of treatment. Furthermore, significant increase in anagen hair and a significant decrease in telogen hair were observed starting from 3 months in male and 1 month in female patients. Thus, the formulations under investigation were effective in attenuating androgenic alopecia‐related hair loss in men and women. 相似文献
993.
994.
Vivien Wai Yun Lai Gang Chen Douglas Gin Rodney Sinclair 《The Australasian journal of dermatology》2019,60(1):e1-e13
A range of systemic treatments are used for alopecia areata with variable evidence supporting efficacy. In this systematic review, we evaluated the evidence surrounding systemic treatments for alopecia areata, alopecia totalis and alopecia universalis. A systematic search was conducted of the peer-reviewed literature published between 1946 and March 2018 via Medline, Embase, Amed, the Cochrane Central Register of Controlled Trials, PsychINFO and Lilacs. All randomised controlled trials (RCTs) that evaluated the effectiveness of systemic treatments for individuals with alopecia areata, totalis or universalis were included. Sixteen studies were included with a total of 768 participants. We found eight placebo-controlled RCTs, three RCTs comparing two systemic treatments and five RCTs comparing three treatments. A total of 15 different systemic therapies were investigated. The most frequently investigated therapy was oral prednisolone pulse therapy and oral inosiplex. There was significant variability in the definition of treatment success. No study evaluated the impact of pharmacotherapy on quality of life using complete quantitative quality of life instruments. Adverse events were reported in 13 studies and were corticosteroid related or otherwise well tolerated. Relapse rates were considerable in the four studies that reported this outcome. There is currently no specific systemic therapy that is supported by robust body of evidence from RCTs. The current evidence suggests efficacy of oral prednisolone pulse therapy and oral inosiplex. Evidence does not support the use of oral zinc sulphate, alefacept and efalizumab. Future RCTs should be adequately powered and employ clearly defined clinical response endpoints to allow future meta-analyses. 相似文献
995.
996.
《Actas dermo-sifiliográficas》2020,111(6):487-495
Background and objectiveFrontal fibrosing alopecia is an increasingly common form of scarring alopecia. The aim of this study was to describe the demographic and clinical characteristics of patients with FFA seen at the trichology unit of a medium-sized regional hospital and to report on treatments used.Material and methodWe reviewed the medical records of all patients with FFA seen at the trichology unit of Hospital Universitario Infanta Sofía in Madrid, Spain between May 2016 and May 2018. We analyzed associations between disease severity, clinical patterns, need for oral medications, and other characteristics.ResultsSeventy-five patients (73 women and 2 men) were studied. Diagnosis was clinical in most cases and 13 cases (17.3%) were confirmed histologically. Median (interquartile range) age at reported onset of symptoms was 61 (12) years. Involvement of the eyebrows was recorded in 70 patients (93.3%) and signs of oral and genital lichen planus in 7 (9.6%). Eleven patients (14.7%) had hypothyroidism and 15 (20.0%) had signs of rosacea. Only 5 of the patients who presented a linear pattern (21.7%) had severe hairline recession. Patients with unstable and/or symptomatic disease (n = 24) were treated with oral medications (5-alpha reductase inhibitors, hydroxychloroquine, corticosteroids, and isotretinoin) or intralesional corticosteroids. Eighteen patients (75.0%) achieved disease stability. Ten of the 15 patients with signs of rosacea and 10 of those with facial papules required systemic treatment.ConclusionMost of the patients in this series of FFA were postmenopausal women. The prevalence of oral and genital lichen planus was higher than that observed in the general population. Patients with a linear pattern had less severe disease. Facial papules were more common in younger patients and both facial papules and rosacea were associated with a greater need for oral treatment. 相似文献
997.
Alexandra Flamm Ata S. Moshiri Fritzlaine Roche Ginikanwa Onyekaba Jennifer Nguyen Alaina J. James Susan Taylor John T. Seykora 《Journal of cutaneous pathology》2020,47(6):530-534
Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia that primarily affects women of African descent. Although histopathological features of CCCA have been described, the pathophysiology of this disease remains unclear. To better understand the components of CCCA pathophysiology, we evaluated the composition of the inflammatory infiltrate, the distribution of Langerhans cells (LCs), and the relationship between fibrosis and perifollicular vessel distribution. Our data indicate that CCCA is associated with a CD4-predominant T-cell infiltrate with increased LCs extending into the lower hair follicle. Fibroplasia associated with follicular scarring displaces blood vessels away from the outer root sheath epithelium. These data indicate that CCCA is an inflammatory scarring alopecia with unique pathophysiologic features that differentiate it from other lymphocytic scarring processes. 相似文献
998.
Jorge Roman MD Nicholas A. Taylor MD PhD Vikash S. Oza MD Randie H. Kim MD PhD 《Journal of cutaneous pathology》2020,47(7):633-637
Nevus psiloliparus is a rare fatty tissue nevus that is a marker for encephalocraniocutaneous lipomatosis, a neurocutaneous syndrome with ocular and central nervous system anomalies. Clinically, nevus psiloliparus is often described as a congenital alopecia and appears as an irregularly shaped, circumscribed area of alopecia on the scalp. Histopathology demonstrates a near-complete absence of mature hair follicles with preservation of arrector pili muscles and mature adipocytes within the dermis. The pathogenesis of nevus psiloliparus may be related to mosaic mutations in fibroblast growth factor receptor 1. Herein we report the histopathological features of a nevus psiloliparus in an 11-year-old girl diagnosed from transverse sections, which show “shadow” follicular units characterized by columns of loosely arranged collagen and a relative paucity of elastic fibers. 相似文献
999.
1000.
Hyunjun Ahn Sang Yeon Lee Won Ju Jung Kye-Ho Lee 《World Journal of Clinical Cases》2021,9(15):3741-3751
BACKGROUNDAlopecia areata (AA) is a common autoimmune disease characterized by hair loss. AA appears in extensive forms, such as progressive and diffusing hair loss (diffuse AA), a total loss of scalp hair (alopecia totalis), and complete loss of hair over the entire body (alopecia universalis). Recently, mesenchymal stem cells (MSCs) have been identified as a therapeutic alternative for autoimmune diseases. For this reason, preclinical and case studies of AA and related diseases using MSCs have been conducted.CASE SUMMARYCase 1: A 55-year-old woman suffered from AA in two areas of the scalp. She was given 15 rounds of minimally manipulated umbilical cord-MSCs (MM-UC-MSCs) over 6 mo. The AA gradually improved 3 mo after the first round. The patient was cured, and AA did not recur. Case 2: A 30-year-old woman, with history of local steroid hormone injections, suffered from AA in one area on the scalp. She was given two rounds of MM-UC-MSCs over 1 mo. The AA immediately improved after the first round. The patient was cured, and AA did not recur. Case 3: A 20-year-old woman, who was diagnosed with alopecia universalis at the age of 12, was given 14 rounds of MM-UC-MSCs over 12 mo. Her hair began to grow about 3 mo after the first round. The patient was cured, and alopecia universalis did not recur.CONCLUSIONMM-UC-MSC transplantation potentially treats patients who suffer from AA and related diseases. 相似文献